Krystal Biotech, Inc. KRYS Pre-Tax Income
Pre-Tax Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s pre-tax income?
- Krystal Biotech, Inc. (KRYS) reported pre-tax income of $61.44M in Q1 2026.
- How has Krystal Biotech, Inc.'s pre-tax income changed year-over-year?
- Krystal Biotech, Inc.'s pre-tax income increased by 40.9% year-over-year, from $43.6M to $61.44M.
- What is the long-term trend for Krystal Biotech, Inc.'s pre-tax income?
- Over 3 years (2021 to 2025), Krystal Biotech, Inc.'s pre-tax income has grown at a 39.6% compound annual growth rate (CAGR), from -$69.57M to $189.47M.
- What does pre-tax income mean?
- Total profit before accounting for income tax payments.
- How do you interpret pre-tax income?
- An increase indicates overall growth in profitability, while a decrease suggests declining performance or rising non-operating costs.
- How does pre-tax income compare across companies?
- Standard measure for comparing profitability across different tax regimes and corporate structures.